User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Primary tabs

download
  • Open access
  • PDF
  • 617.01 K
Frentz, Dineke [Erasmus Medical Center, Rotterdam] Van de Vijver, David AMC [Erasmus Medical Center, Rotterdam] Abecasis, Ana B [Universidade Nova de Lisboa, Lisboa, Portugal] Albert, Jan [Karolinska Institutet, Stockhlom, Sweden] Hamouda, Osamah [Robert Koch, Institute, Berlin, Germany] Goubau, Patrick [UCL] Yombi, Jean Cyr [UCL] Vandercam, Bernard [UCL] Vekemans, Marie-Christiane [UCL]

Background One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance mutations (TDRM) using data from the European Spread program. Methods Clinical, epidemiological and virological data from 4317 patients newly diagnosed with HIV-1 infection between 2002 and 2007 were analysed. Patients were enrolled using a pre-defined sampling strategy. Results The overall prevalence of TDRM in this period was 8.9% (95% CI: 8.1-9.8). Interestingly, significant changes over time in TDRM caused by the different drug classes were found. Whereas nucleoside resistance mutations remained constant at 5%, a significant decline in protease inhibitors resistance mutations was observed, from 3.9% in 2002 to 1.6% in 2007 (p = 0.001). In contrast, resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) doubled from 2.0% in 2002 to 4.1% in 2007 (p = 0.004) with 58% of viral strains carrying a K103N mutation. Phylogenetic analysis showed that these temporal changes could not be explained by large clusters of TDRM. Conclusion During the years 2002 to 2007 transmitted resistance to NNRTI has doubled to 4% in Europe. The frequent use of NNRTI in first-line regimens and the clinical impact of NNRTI mutations warrants continued monitoring.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2014
Language Anglais
Journal information "BMC Infectious Diseases" - Vol. 14, p. 407 (2014)
Peer reviewed yes
Publisher BioMed Central Ltd. ((United Kingdom) London)
e-issn 1471-2334
Publication status Publié
Affiliations UCL - SSS/IREC/MBLG - Pôle de Microbiologie médicale
UCL - (SLuc) Service de microbiologie
UCL - (SLuc) Service de médecine interne et maladies infectieuses (MIMI)
UCL - (SLuc) Service d'hématologie
Keywords Europe ; HIV-1 ; Resistance ; Transmission
Links
  1. Palella Frank J., Delaney Kathleen M., Moorman Anne C., Loveless Mark O., Fuhrer Jack, Satten Glen A., Aschman Diane J., Holmberg Scott D., Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection, 10.1056/nejm199803263381301
  2. Vercauteren Jurgen, Wensing Annemarie M. J., van de Vijver David A. M. C., Albert Jan, Balotta Claudia, Hamouda Osamah, Kücherer Claudia, Struck Daniel, Schmit Jean‐Claude, Åsjö Birgitta, Bruckova Marie, Camacho Ricardo J., Clotet Bonaventura, Coughlan Suzie, Grossman Zehava, Horban Andrzej, Korn Klaus, Kostrikis Leondios, Nielsen Claus, Paraskevis Dimitrios, Poljak Mario, Puchhammer‐Stöckl Elisabeth, Riva Chiara, Ruiz Lidia, Salminen Mika, Schuurman Rob, Sonnerborg Anders, Stanekova Danica, Stanojevic Maja, Vandamme Anne‐Mieke, Boucher Charles A. B., Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe, 10.1086/644505
  3. Bannister Wendy P, Cozzi-Lepri Alessandro, Clotet Bonaventura, Mocroft Amanda, Kjær Jesper, Reiss Peter, Wyl Viktor von, Lazzarin Adriano, Katlama Christine, Phillips Andrew N, Ruiz Lidia, Lundgren Jens D, Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study : , 10.1097/qai.0b013e31817ae5c0
  4. Booth Clare L., Garcia-Diaz Ana M., Youle Michael S., Johnson Margaret A., Phillips Andrew, Geretti Anna Maria, Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection, 10.1093/jac/dkl501
  5. Yerly Sabine, von Wyl Viktor, Ledergerber Bruno, Böni Jürg, Schüpbach Jörg, Bürgisser Philippe, Klimkait Thomas, Rickenbach Martin, Kaiser Laurent, Günthard Huldrych F, Perrin Luc, Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey : , 10.1097/qad.0b013e3282f0b685
  6. Wheeler William H, Ziebell Rebecca A, Zabina Helena, Pieniazek Danuta, Prejean Joseph, Bodnar Ulana R, Mahle Kristen C, Heneine Walid, Johnson Jeffrey A, Hall H Irene, Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.–2006 : , 10.1097/qad.0b013e3283388742
  7. Hurt CB, McCoy SI, Kuruc J, Nelson JA, Kerkau M, Fiscus S, McGee K, Sebastian J, Leone P, Pilcher C, Hicks C, Eron J: Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007. Antivir Ther. 2009, 14 (5): 673-678.
  8. Wittkop Linda, Günthard Huldrych F, de Wolf Frank, Dunn David, Cozzi-Lepri Alessandro, de Luca Andrea, Kücherer Claudia, Obel Niels, von Wyl Viktor, Masquelier Bernard, Stephan Christoph, Torti Carlo, Antinori Andrea, García Federico, Judd Ali, Porter Kholoud, Thiébaut Rodolphe, Castro Hannah, van Sighem Ard I, Colin Céline, Kjaer Jesper, Lundgren Jens D, Paredes Roger, Pozniak Anton, Clotet Bonaventura, Phillips Andrew, Pillay Deenan, Chêne Geneviève, Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study, 10.1016/s1473-3099(11)70032-9
  9. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes : , 10.1097/qad.0b013e3282f5e062
  10. Countries in the WHO European Region. [ http://www.who.int/about/regions/euro/en/index.html ]
  11. Bennett Diane E., Camacho Ricardo J., Otelea Dan, Kuritzkes Daniel R., Fleury Hervé, Kiuchi Mark, Heneine Walid, Kantor Rami, Jordan Michael R., Schapiro Jonathan M., Vandamme Anne-Mieke, Sandstrom Paul, Boucher Charles A. B., van de Vijver David, Rhee Soo-Yon, Liu Tommy F., Pillay Deenan, Shafer Robert W., Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update, 10.1371/journal.pone.0004724
  12. Frentz Dineke, Wensing Annemarie M J, Albert Jan, Paraskevis Dimitrios, Abecasis Ana B, Hamouda Osamah, Jørgensen Louise B, Kücherer Claudia, Struck Daniel, Schmit Jean-Claude, Åsjö Birgitta, Balotta Claudia, Beshkov Danail, Camacho Ricardo J, Clotet Bonaventura, Coughlan Suzie, De Wit Stéphane, Griskevicius Algirdas, Grossman Zehava, Horban Andrzej, Kolupajeva Tatjana, Korn Klaus, Kostrikis Leondios G, Liitsola Kirsi, Linka Marek, Nielsen Claus, Otelea Dan, Paredes Roger, Poljak Mario, Puchhammer-Stöckl Elisabeth, Sönnerborg Anders, Stanekova Danica, Stanojevic Maja, Vandamme Anne-Mieke, Boucher Charles A B, Van de Vijver David A M C, , Limited cross-border infections in patients newly diagnosed with HIV in Europe, 10.1186/1742-4690-10-36
  13. de Oliveira T., Deforche K., Cassol S., Salminen M., Paraskevis D., Seebregts C., Snoeck J., van Rensburg E. J., Wensing A. M. J., van de Vijver D. A., Boucher C. A., Camacho R., Vandamme A.-M., An automated genotyping system for analysis of HIV-1 and other microbial sequences, 10.1093/bioinformatics/bti607
  14. Posada D., Crandall K. A., MODELTEST: testing the model of DNA substitution, 10.1093/bioinformatics/14.9.817
  15. Hillis D. M., Bull J. J., An Empirical Test of Bootstrapping as a Method for Assessing Confidence in Phylogenetic Analysis, 10.1093/sysbio/42.2.182
  16. Gifford R. J., de Oliveira T., Rambaut A., Pybus O. G., Dunn D., Vandamme A.-M., Kellam P., Pillay D., , Phylogenetic Surveillance of Viral Genetic Diversity and the Evolving Molecular Epidemiology of Human Immunodeficiency Virus Type 1, 10.1128/jvi.00889-07
  17. Yeni Patrick G., Hammer Scott M., Carpenter Charles C. J., Cooper David A., Fischl Margaret A., Gatell Jose M., Gazzard Brian G., Hirsch Martin S., Jacobsen Donna M., Katzenstein David A., Montaner Julio S. G., Richman Douglas D., Saag Michael S., Schechter Mauro, Schooley Robert T., Thompson Melanie A., Vella Stefano, Volberding Paul A., Antiretroviral Treatment for Adult HIV Infection in 2002 : Updated Recommendations of the International AIDS Society-USA Panel, 10.1001/jama.288.2.222
  18. Yeni Patrick G., Hammer Scott M., Hirsch Martin S., Saag Michael S., Schechter Mauro, Carpenter Charles C. J., Fischl Margaret A., Gatell Jose M., Gazzard Brian G., Jacobsen Donna M., Katzenstein David A., Montaner Julio S. G., Richman Douglas D., Schooley Robert T., Thompson Melanie A., Vella Stefano, Volberding Paul A., Treatment for Adult HIV Infection : 2004 Recommendations of the International AIDS Society-USA Panel, 10.1001/jama.292.2.251
  19. Hammer Scott M., Saag Michael S., Schechter Mauro, Montaner Julio S. G., Schooley Robert T., Jacobsen Donna M., Thompson Melanie A., Carpenter Charles C. J., Fischl Margaret A., Gazzard Brian G., Gatell Jose M., Hirsch Martin S., Katzenstein David A., Richman Douglas D., Vella Stefano, Yeni Patrick G., Volberding Paul A., Treatment for Adult HIV Infection : 2006 Recommendations of the International AIDS Society–USA Panel, 10.1001/jama.296.7.827
  20. Hammer Scott M., Eron Joseph J., Reiss Peter, Schooley Robert T., Thompson Melanie A., Walmsley Sharon, Cahn Pedro, Fischl Margaret A., Gatell Jose M., Hirsch Martin S., Jacobsen Donna M., Montaner Julio S. G., Richman Douglas D., Yeni Patrick G., Volberding Paul A., Antiretroviral Treatment of Adult HIV Infection : 2008 Recommendations of the International AIDS Society–USA Panel, 10.1001/jama.300.5.555
  21. , Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study, 10.1136/bmj.38665.534595.55
  22. Vercauteren Jurgen, Derdelinckx Inge, Sasse André, Bogaert Marleen, Ceunen Helga, De Roo Ann, De Wit Stephane, Deforche Koen, Echahidi Fedoua, Fransen Katrien, Goffard Jean-Christophe, Goubau Patrick, Goudeseune Elodie, Yombi Jean-Cyr, Lacor Patrick, Liesnard Corinne, Moutschen Michel, Pierard Denis, Rens Roeland, Schrooten Yoeri, Vaira Dolores, van den Heuvel Annelies, van der Gucht Bea, van Ranst Marc, van Wijngaerden Eric, Vandercam Bernard, Vekemans Marc, Verhofstede Chris, Clumeck Nathan, Vandamme Anne-Mieke, van Laethem Kristel, Prevalence and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006, 10.1089/aid.2007.0212
  23. Bracciale L., Colafigli M., Zazzi M., Corsi P., Meraviglia P., Micheli V., Maserati R., Gianotti N., Penco G., Setti M., Di Giambenedetto S., Butini L., Vivarelli A., Trezzi M., De Luca A., Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors, 10.1093/jac/dkp246
  24. Bartmeyer Barbara, Kuecherer Claudia, Houareau Claudia, Werning Johanna, Keeren Kathrin, Somogyi Sybille, Kollan Christian, Jessen Heiko, Dupke Stephan, Hamouda Osamah, , Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort, 10.1371/journal.pone.0012718
  25. Karlsson Annika, Björkman Per, Bratt Göran, Ekvall Håkan, Gisslén Magnus, Sönnerborg Anders, Mild Mattias, Albert Jan, Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003–2010, 10.1371/journal.pone.0033484
  26. , Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study, 10.1136/bmj.e5253
  27. Jain Vivek, Liegler Teri, Vittinghoff Eric, Hartogensis Wendy, Bacchetti Peter, Poole Lauren, Loeb Lisa, Pilcher Christopher D., Grant Robert M., Deeks Steven G., Hecht Frederick M., Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009, 10.1371/journal.pone.0015510
  28. Lockman S., Hughes M.D., McIntyre J., Zheng Y., Chipato T., Conradie F., Sawe F., Asmelash A., Hosseinipour M.C., Mohapi L., Stringer E., Mngqibisa R., Siika A., Atwine D., Hakim J., Shaffer D., Kanyama C., Wools-Kaloustian K., Salata R.A., Hogg E., Alston-Smith B., Walawander A., Purcelle-Smith E., Eshleman S., Rooney J., Rahim S., Mellors J.W., Schooley R.T., Currier J.S., Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure, 10.1056/nejmoa0906626
  29. Pingen M., Nijhuis M., de Bruijn J. A., Boucher C. A. B., Wensing A. M. J., Evolutionary pathways of transmitted drug-resistant HIV-1, 10.1093/jac/dkr157
  30. Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom : , 10.1097/qad.0b013e3280b07761
  31. Bezemer Daniela, van Sighem Ard, Lukashov Vladimir V, van der Hoek Lia, Back Nicole, Schuurman Rob, Boucher Charles AB, Claas Eric CJ, Boerlijst Maarten C, Coutinho Roel A, de Wolf Frank, Transmission networks of HIV-1 among men having sex with men in the Netherlands : , 10.1097/qad.0b013e328333ddee
  32. Turner D, Amit S, Chalom S, Penn O, Pupko T, Katchman E, Matus N, Tellio H, Katzir M, Avidor B: Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naive patients in Tel Aviv, Israel. HIV Med. 2012, 13 (4): 202-206.
  33. Carpenter Charles C. J., Cooper David A., Fischl Margaret A., Gatell Jose M., Gazzard Brian G., Hammer Scott M., Hirsch Martin S., Jacobsen Donna M., Katzenstein David A., Montaner Julio S. G., Richman Douglas D., Saag Michael S., Schechter Mauro, Schooley Robert T., Thompson Melanie A., Vella Stefano, Yeni Patrick G., Volberding Paul A., Antiretroviral Therapy in Adults : Updated Recommendations of the International AIDS Society–USA Panel, 10.1001/jama.283.3.381
  34. Staszewski Schlomo, Morales-Ramirez Javier, Tashima Karen T., Rachlis Anita, Skiest Daniel, Stanford James, Stryker Richard, Johnson Philip, Labriola Dominic F., Farina Dianne, Manion Douglas J., Ruiz Nancy M., Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults, 10.1056/nejm199912163412501
  35. Riddler Sharon A., Haubrich Richard, DiRienzo A. Gregory, Peeples Lynne, Powderly William G., Klingman Karin L., Garren Kevin W., George Tania, Rooney James F., Brizz Barbara, Lalloo Umesh G., Murphy Robert L., Swindells Susan, Havlir Diane, Mellors John W., Class-Sparing Regimens for Initial Treatment of HIV-1 Infection, 10.1056/nejmoa074609
  36. Parienti Jean‐Jacques, Bangsberg David R., Verdon Renaud, Gardner Edward M., Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis, 10.1086/596482
  37. Smit Mikaela, Smit Colette, Geerlings Suzanne, Gras Luuk, Brinkman Kees, Hallett Timothy B., de Wolf Frank, , Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands, 10.1371/journal.pone.0076071
  38. van de Vijver David A., Wensing Annemarie M. J., Angarano Gioacchino, ??sj?? Birgitta, Balotta Claudia, Boeri Enzo, Camacho Ricardo, Chaix Marie-Laure, Costagliola Dominique, De Luca Andrea, Derdelinckx Inge, Grossman Zehava, Hamouda Osamah, Hatzakis Angelos, Hemmer Robert, Hoepelman Andy, Horban Andrzej, Korn Klaus, K??cherer Claudia, Leitner Thomas, Loveday Clive, MacRae Eilidh, Maljkovic Irina, de Mendoza Carmen, Meyer Laurence, Nielsen Claus, Op de Coul Eline L. M., Ormaasen Vidar, Paraskevis Dimitris, Perrin Luc, Puchhammer-St??ckl Elisabeth, Ruiz Lidia, Salminen Mika, Schmit Jean-Claude, Schneider Francois, Schuurman Rob, Soriano Vincent, Stanczak Grzegorz, Stanojevic Maja, Vandamme Anne-Mieke, Van Laethem Kristel, Violin Michela, Wilbe Karin, Yerly Sabine, Zazzi Maurizio, Boucher Charles A. B., The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes : , 10.1097/01.qai.0000209899.05126.e4
  39. Gallant Joel E., DeJesus Edwin, Arribas José R., Pozniak Anton L., Gazzard Brian, Campo Rafael E., Lu Biao, McColl Damian, Chuck Steven, Enejosa Jeffrey, Toole John J., Cheng Andrew K., Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV, 10.1056/nejmoa051871
  40. Jain Vivek, Sucupira Maria C., Bacchetti Peter, Hartogensis Wendy, Diaz Ricardo S., Kallas Esper G., Janini Luiz M., Liegler Teri, Pilcher Christopher D., Grant Robert M., Cortes Rodrigo, Deeks Steven G., Hecht Frederick M., Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes, 10.1093/infdis/jiq167
  41. Kikaire Ben, Khoo Saye, Walker A Sarah, Ssali Francis, Munderi Paula, Namale Letitia, Reid Andrew, Gibb Diana M, Mugyenyi Peter, Grosskurth Heiner, Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy : , 10.1097/qad.0b013e3280121801
  42. Bartlett JA, Buda JJ, von Scheele B, Mauskopf JA, Davis EA, Elston R, King MS, Lanier ER: Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview. J Acquir Immune Defic Syndr. 2006, 41 (3): 323-331.
  43. Gupta Ravindra, Hill Andrew, Sawyer Anthony W., Pillay Deenan, Emergence of Drug Resistance in HIV Type 1–Infected Patients after Receipt of First‐Line Highly Active Antiretroviral Therapy: A Systematic Review of Clinical Trials, 10.1086/590943
  44. Lima Viviane D., Gill Vikram S., Yip Benita, Hogg Robert S., Montaner Julio S. G., Harrigan P. Richard, Increased Resilience to the Development of Drug Resistance with Modern Boosted Protease Inhibitor–Based Highly Active Antiretroviral Therapy, 10.1086/588675
  45. Elzi Luigia, Erb Stefan, Furrer Hansjakob, Ledergerber Bruno, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Bernasconi Enos, Weber Rainer, Battegay Manuel, Swiss HIV Cohort Study for the, Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection : Determinants and Outcomes, 10.1001/archinternmed.2012.3216
  46. Vo Thi Tuyet Nhung, Ledergerber Bruno, Keiser Olivia, Hirschel Bernard, Furrer Hansjakob, Battegay Manuel, Cavassini Matthias, Bernasconi Enos, Vernazza Pietro, Weber Rainer, , Durability and Outcome of Initial Antiretroviral Treatments Received during 2000–2005 by Patients in the Swiss HIV Cohort Study, 10.1086/588141
  47. Schuurman Rob, Brambilla Donald, de Groot Tom, Huang Diana, Land Sally, Bremer James, Benders Ireen, Boucher Charles A.B., Underestimation of HIV Type 1 Drug Resistance Mutations: Results from the ENVA-2 Genotyping Proficiency Program, 10.1089/088922202753472801
  48. Li Jonathan Z., Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure : A Systematic Review and Pooled Analysis, 10.1001/jama.2011.375
  49. Wensing Annemarie M. J., van de Vijver David A., Angarano Gioacchino, Åsjö Birgitta, Balotta Claudia, Boeri Enzo, Camacho Ricardo, Chaix Maire‐Laure, Costagliola Dominique, De Luca Andrea, Derdelinckx Inge, Grossman Zehava, Hamouda Osamah, Hatzakis Angelos, Hemmer Robert, Hoepelman Andy, Horban Andrzej, Korn Klaus, Kücherer Claudia, Leitner Thomas, Loveday Clive, MacRae Eilidh, Maljkovic Irina, de Mendoza Carmen, Meyer Laurence, Nielsen Claus, Op de Coul Eline L., Ormaasen Vidar, Paraskevis Dimitris, Perrin Luc, Puchhammer‐Stöckl Elisabeth, Ruiz Lidia, Salminen Mika, Schmit Jean‐Claude, Schneider Francois, Schuurman Rob, Soriano Vincent, Stanczak Grzegorz, Stanojevic Maja, Vandamme Anne‐Mieke, Van Laethem Kristel, Violin Michela, Wilbe Karin, Yerly Sabine, Zazzi Maurizio, Boucher Charles A., , Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management, 10.1086/432916
Bibliographic reference Frentz, Dineke ; Van de Vijver, David AMC ; Abecasis, Ana B ; Albert, Jan ; Hamouda, Osamah ; et. al. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. In: BMC Infectious Diseases, Vol. 14, p. 407 (2014)
Permanent URL http://hdl.handle.net/2078.1/157396